Actavia Life Sciences, Inc. (RASP)

Actavia Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	0.07	0.04	0.01	0.01	0.05
Cash & Short-Term Investments	0.07	0.04	0.01	0.01	0.05
Cash Growth	90.50%	262.86%	-23.83%	-71.56%	17.27%
Prepaid Expenses	0.02	0.05	0.03	0.02	0.01
Other Current Assets	-	-	-	0	0.01
Total Current Assets	0.1	0.09	0.04	0.03	0.07
Property, Plant & Equipment	-	-	-	0	0
Goodwill	-	-	-	-	2.72
Other Intangible Assets	-	-	-	-	2.15
Total Assets	0.1	0.09	0.04	0.03	4.95
Accounts Payable	0.96	0.82	0.9	0.95	0.86
Accrued Expenses	0.88	0.72	1.18	1.23	1.28
Short-Term Debt	0.21	0.13	0.68	0.52	0.26
Other Current Liabilities	0	0.01	0.04	-	-
Total Current Liabilities	2.05	1.68	2.8	2.71	2.41
Long-Term Debt	-	0.09	-	-	-
Total Liabilities	2.05	1.77	2.8	2.71	2.41
Common Stock	0.77	0.18	0.07	0.07	0.07
Additional Paid-In Capital	25.94	22.35	20.71	19.91	19.78
Retained Earnings	-28.66	-24.22	-23.53	-22.66	-17.31
Shareholders' Equity	-1.96	-1.69	-2.75	-2.67	2.54
Total Liabilities & Equity	0.1	0.09	0.04	0.03	4.95
Total Debt	0.21	0.22	0.68	0.52	0.26
Net Cash (Debt)	-0.14	-0.18	-0.67	-0.51	-0.21
Net Cash Per Share	-0.00	-0.00	-0.01	-0.01	-0.00
Filing Date Shares Outstanding	771.81	771.81	179.98	68.91	68.91
Total Common Shares Outstanding	771.81	179.98	68.91	68.91	68.91
Working Capital	-1.96	-1.6	-2.75	-2.68	-2.34
Book Value Per Share	-0.00	-0.01	-0.04	-0.04	0.04
Tangible Book Value	-1.96	-1.69	-2.75	-2.67	-2.34
Tangible Book Value Per Share	-0.00	-0.01	-0.04	-0.04	-0.03

Updated May 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.